Literature DB >> 28010783

Minority underrepresentation in cardiovascular outcome trials for type 2 diabetes.

Charis Hoppe1, David Kerr2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28010783     DOI: 10.1016/S2213-8587(16)30324-2

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN: 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  10 in total

1.  Real-World Evidence Should Be Used in Regulatory Decisions About New Pharmaceutical and Medical Device Products for Diabetes.

Authors:  David C Klonoff; Alberto Gutierrez; Alexander Fleming; David Kerr
Journal:  J Diabetes Sci Technol       Date:  2019-04-03

2.  Effects of Communication Source and Racial Representation in Clinical Trial Recruitment Flyers.

Authors:  Sungkyoung Lee; Namyeon Lee; Ciera Elaine Kirkpatrick
Journal:  Health Commun       Date:  2021-09-16

3.  Does weight management research for adults with severe obesity represent them? Analysis of systematic review data.

Authors:  Clare Robertson; Magaly Aceves-Martins; Moira Cruickshank; Mari Imamura; Alison Avenell
Journal:  BMJ Open       Date:  2022-05-31       Impact factor: 3.006

4.  Digital Diabetes Data and Artificial Intelligence: A Time for Humility Not Hubris.

Authors:  David Kerr; David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2018-09-05

5.  Barriers and Solutions to a Recently Noted Failure of Diabetes Care Outcomes to Improve From 2005 to 2016 in the United States.

Authors:  David C Klonoff; Robert A Gabbay; David Kerr
Journal:  J Diabetes Sci Technol       Date:  2019-10-09

Review 6.  The Representation of Gender and Race/Ethnic Groups in Randomized Clinical Trials of Individuals with Systemic Lupus Erythematosus.

Authors:  Titilola Falasinnu; Yashaar Chaichian; Michelle B Bass; Julia F Simard
Journal:  Curr Rheumatol Rep       Date:  2018-03-17       Impact factor: 4.592

7.  The representation of Indigenous peoples in chronic disease clinical trials in Australia, Canada, New Zealand, and the United States.

Authors:  Valerie Umaefulam; Tessa Kleissen; Cheryl Barnabe
Journal:  Clin Trials       Date:  2022-01-06       Impact factor: 2.486

8.  Improving diversity in study participation: Patient perspectives on barriers, racial differences and the role of communities.

Authors:  Lisa Shea; Jacqueline Pesa; Gabrielle Geonnotti; Valerie Powell; Caryl Kahn; Wesley Peters
Journal:  Health Expect       Date:  2022-06-28       Impact factor: 3.318

Review 9.  Disparities in Cardiovascular Care and Outcomes for Women From Racial/Ethnic Minority Backgrounds.

Authors:  Sujana Balla; Sofia Elena Gomez; Fatima Rodriguez
Journal:  Curr Treat Options Cardiovasc Med       Date:  2020-11-17

10.  Racial disparity in atherosclerotic cardiovascular disease in hospitalized patients with diabetes 2005-2015: Potential warning signs for future U.S. public health.

Authors:  Gursukhmandeep Singh Sidhu; Charisse Ward; Keith C Ferdinand
Journal:  Am J Prev Cardiol       Date:  2020-10-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.